Sort
48,018 grants matching “immunotherapy”
Transformative personalized vascular disrupting cancer immunotherapy
$615,146George Coukos · University Of Pennsylvania · R01 · FY2011 · CA
Long-Term Cardiovascular Sequelae of Cancer Immunotherapies
$615,145Javid J Moslehi · University Of California, San Francisco · R01 · FY2025 · HL
Mechanisms of vasomotion-mediated perivascular clearance in cerebral amyloid angiopathy
$615,131Susanne Janneke Van Veluw · Massachusetts General Hospital · R01 · FY2022 · NS
Fecal microbial transplantation for chemotherapy behavioral side effects
$615,068Leah M Pyter · Ohio State University · R01 · FY2024 · CA
CD4 T cell control of cytomegalovirus
$615,063Christopher A Benedict · La Jolla Institute For Immunology · R01 · FY2021 · AI
CD4 T cell control of cytomegalovirus
$615,063Christopher A Benedict · La Jolla Institute For Immunology · R01 · FY2022 · AI
Defining the four major routes of MHC class II antigen processing and presentation with influenza antigens
$614,983Laurence Crane Eisenlohr · Children'S Hosp Of Philadelphia · R01 · FY2024 · AI
Outcomes for CLL patients treated with novel therapy
$614,982Neil E Kay · Mayo Clinic Rochester · R01 · FY2023 · CA
Regulatory T cells in cancer therapy
$614,963Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2024 · CA
CTL-killing capacity and cancer stiffness in cancer immunity and therapy
$614,951Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2024 · CA
Induced tolerogenic dendritic cell therapy of allergic diseases
$614,922Ulrich H Von Andrian · Massachusetts General Hospital · U19 · FY2014 · AI
Transcriptional Reprogramming in Melanoma Plasticity
$614,911Chengyu Liang · Wistar Institute · R01 · FY2024 · CA
Enhancing Adoptive Immunotherapy Targeting Pediatric High-Grade Gliomas
$614,852Duane A. Mitchell · University Of Florida · R01 · FY2019 · CA
Defining neoantigen immunodominance for antigen selection and biomarker discovery in human pancreatic cancer immunotherapy
$614,801Vinod P Balachandran · Sloan-Kettering Inst Can Research · U01 · FY2021 · CA
Reprogramming myeloid cell metabolism to prevent cognitive aging and Alzheimer's Disease
$614,758Katrin I Andreasson · Stanford University · R01 · FY2024 · AG
Early prediction of lethal phenotypes in triple negative breast cancer using multiscale, multi-modality platforms
$614,757Sunil S. Badve · Emory University · R01 · FY2024 · CA
Naive T cells in Cancer Immune Evasion and Immunotherapy
$614,741Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2019 · CA
Immunotherapy Targeting Tau Aggregate Polymorphs
$614,629Rakez Kayed · University Of Texas Med Br Galveston · R01 · FY2025 · AG
T Cell-Specific BRCA1 Function in Antitumor Immunity and Immunotherapy
$614,606Rong Li · George Washington University · R01 · FY2023 · CA
T Cell-Specific BRCA1 Function in Antitumor Immunity and Immunotherapy
$614,606Rong Li · George Washington University · R01 · FY2025 · CA
Identification of REV-ERB inverse agonists for cancer immunotherapy
$614,469Laura A Solt · University Of Florida · R01 · FY2022 · CA
Dissecting the role of hypoxia in T cell differentiation in cancer
$614,462Greg M. Delgoffe · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
Dissecting the role of hypoxia in T cell differentiation in cancer
$614,462Greg M. Delgoffe · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · CA
Adrenergic modulation of cellular immune functions in CAR T cell-induced cytokine release syndrome
$614,372Verena Staedtke · Johns Hopkins University · U01 · FY2022 · CA
Adrenergic modulation of cellular immune functions in CAR T cell-induced cytokine release syndrome
$614,362Verena Staedtke · Johns Hopkins University · U01 · FY2021 · CA